“…However, with the emergence of resistance, current regimens advocate combined treatment with isoniazid, rifampin, pyrazinamide, and ethambutol for a duration of 7 to 18 months. 4,5 In conclusion, we report a case of CTB in a nonendemic area. With the increase in globalization, it is essential for every dermatologist to consider the possibility of CTB.…”